Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Upbound Group, Inc. Announces New Independent Director Charu Jain
-
Rocket Lab Appoints Chief Operations Officer to Support Company Growth
-
MINT Strengthens its Board of Directors with the Addition of a Global Technology Executive
-
SolarEdge Unveils Next Generation All-in-One Home Solar + Storage Solution at RE+ 2024
-
D-Wave to Showcase the Impact of Quantum-Powered Optimization at Info-Tech LIVE
-
Laser Photonics Shares Concept Animation of Next-Gen CleanTech Robotic Cell
-
Matternet Receives First Light UAS Operator Certificate from Swiss Federal Office of Civil Aviation for Advanced Drone Operations
-
Xcell Biosciences Advances Labcorp Collaboration with Novel Platform for Automated Cell and Gene Therapy Manufacturing
-
Fervo Energy’s Record-Breaking Production Results Showcase Rapid Scale Up of Enhanced Geothermal
-
Meketa Capital Launches Infrastructure Fund on Schwab’s Mutual Fund Marketplace
-
Oppenheimer Names Aaron Stowell Managing Director and Branch Manager of Atlanta Office
-
World Wide Technology Named One of Fast Company’s 100 Best Workplaces for Innovators
-
Incendia Therapeutics Enrolls First Patient in Phase 1c Clinical Trial of PRTH-101, a Novel DDR1 Inhibitor
-
MSC Income Fund, Inc. Files Definitive Proxy Statement in Connection with Potential Listing of its Shares on a National Securities Exchange
-
Stoke Therapeutics Presents Zorevunersen Data Showing Substantial Reductions in Seizures and Improvements in Multiple Measures of Cognition and Behavior That Support the Potential for Disease Modifica
-
Rocket Pharmaceuticals Announces Appointment of Mikael Dolsten, M.D., Ph.D., to Board of Directors
-
BCN to Participate in September 11 National Day of Service and Remembrance
-
The Greenery Picks Rootstock ERP and Salesforce to Harvest Growth and Reap Operational Efficiencies
-
edatanetworks Inc. Augmented Reality Patent Approved by USPTO
-
Wills Group Selects SymphonyAI Connected Retail to Create Engaging, High-Quality Shopper Experience
-
KalVista Pharmaceuticals to Participate in the 2024 Cantor Global Healthcare Conference
-
Algorhythm Holdings Announces Changes to Board of Directors
-
Entero Therapeutics Signs Letter of Intent to License and Commercialize Remote Patient and Machine Vision Clinical Trial Management Platform from Data Vault Holdings
-
Purple Biotech to Present Data for its Lead Oncology Drug CM24 at the AACR Special Conference on Advances in Pancreatic Cancer Research
-
OKYO Pharma Announces Chairman Acquires Shares
-
Beamr Brings Live Streaming to the Next Level With NVIDIA Holoscan for Media
-
TransCode Therapeutics Announces Publication of Study with Lead Therapeutic Candidate Revealing Mechanisms Behind Candidate’s Preclinical Efficacy Against Metastatic Cancer
-
AirBoss Announces U.S. Federal Government Contract for Personal Protective Equipment Valued at up to US$84 Million
-
Bitfarms Enhances Operations Teams
-
Cielo Provides Update on Binding Letter of Intent to Acquire Carseland Facility from Rocky Mountain Clean Fuels Inc., Announces Engagement of Integral Wealth Securities as Market Maker, and Terminate
-
ACELYRIN, INC. Announces Positive Proof-of-Concept Data From Phase 1/2 Clinical Trial of Lonigutamab as a Subcutaneous Treatment for Thyroid Eye Disease to be Presented at 42nd Annual Meeting of Europ
-
Cibus Completes First Field Trials in UK for Pod Shatter Reduction in Winter Oilseed Rape
-
Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers
-
Perspective Therapeutics Presents at the World Molecular Imaging Congress 2024
-
Iterum Therapeutics Provides Update on FDA Advisory Committee Discussion of Oral Sulopenem for the Treatment of uUTI in Adult Women
-
Report Names Most Challenging Cities for Living with Asthma in 2024
-
Solaris Identifies Additional Veins as Celestina Epithermal Target Takes Shape; Reports 16,019 g/t Silver and 25.3 g/t Gold in Follow-Up Sampling
-
C4 Therapeutics Announces Delivery of Second Development Candidate to Biogen
-
ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference
-
Mural Oncology to Host First Virtual Investor Day on September 26, 2024
-
TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization
-
Aclaris Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference
-
Virtu Financial Announces Direct Connectivity of Triton Valor EMS to Tokyo Stock Exchange’s CONNEQTOR
-
GXO appoints Emmanuel Bonnet as Vice President of Business Development in France
-
CHARM Therapeutics appoints Dr Beverley Carr as Chief Business Officer
-
Accenture to Announce Fourth-Quarter and Full-Year Fiscal 2024 Results
-
Linglong Tire becomes official Global Partner of Chelsea Football Club
-
Flipster Announces Silver Sponsorship for Token2049
-
Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
-
SLB achieves breakthrough results in sustainable lithium production
